2.97
Goodrx Holdings Inc stock is traded at $2.97, with a volume of 1.84M.
It is down -3.26% in the last 24 hours and down -28.26% over the past month.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
See More
Previous Close:
$3.07
Open:
$3
24h Volume:
1.84M
Relative Volume:
0.38
Market Cap:
$292.78M
Revenue:
$775.09M
Net Income/Loss:
$-58.68M
P/E Ratio:
-22.40
EPS:
-0.1326
Net Cash Flow:
$64.06M
1W Performance:
-4.50%
1M Performance:
-28.26%
6M Performance:
-30.44%
1Y Performance:
-34.87%
Goodrx Holdings Inc Stock (GDRX) Company Profile
Name
Goodrx Holdings Inc
Sector
Industry
Phone
(855) 268-2822
Address
2701 OLYMPIC BOULEVARD, SANTA MONICA
Compare GDRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
GDRX
Goodrx Holdings Inc
|
2.97 | 1.04B | 775.09M | -58.68M | 64.06M | -0.1326 |
|
VEEV
Veeva Systems Inc
|
293.36 | 47.81B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
68.48 | 12.09B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
101.77 | 8.57B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
49.62 | 9.36B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
35.32 | 6.84B | 906.14M | -52.62M | 89.62M | -0.3621 |
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-11-25 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Aug-09-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| May-23-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| May-16-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-10-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-01-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-02-24 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-10-23 | Upgrade | DA Davidson | Neutral → Buy |
| Jul-31-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Dec-01-22 | Initiated | Citigroup | Buy |
| Nov-04-22 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-12-22 | Initiated | DA Davidson | Neutral |
| Jun-10-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-06-22 | Resumed | BofA Securities | Buy |
| Jun-01-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-10-22 | Downgrade | Evercore ISI | Outperform → In-line |
| May-10-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-10-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-10-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-11-22 | Initiated | Wells Fargo | Equal Weight |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Neutral |
| Mar-15-22 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-01-22 | Reiterated | Barclays | Overweight |
| Mar-01-22 | Reiterated | BofA Securities | Neutral |
| Mar-01-22 | Downgrade | Cowen | Outperform → Market Perform |
| Mar-01-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Mar-01-22 | Reiterated | Evercore ISI | Outperform |
| Mar-01-22 | Reiterated | Goldman | Buy |
| Mar-01-22 | Reiterated | JP Morgan | Underweight |
| Mar-01-22 | Reiterated | RBC Capital Mkts | Outperform |
| Mar-01-22 | Reiterated | SVB Leerink | Outperform |
| Jan-07-22 | Initiated | Goldman | Buy |
| Dec-21-21 | Initiated | Stephens | Overweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Aug-31-21 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-13-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| Apr-06-21 | Resumed | Evercore ISI | Outperform |
| Jan-25-21 | Initiated | Guggenheim | Buy |
| Nov-19-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-18-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-19-20 | Initiated | Barclays | Equal Weight |
| Oct-19-20 | Initiated | BofA Securities | Neutral |
| Oct-19-20 | Initiated | Citigroup | Buy |
| Oct-19-20 | Initiated | Cowen | Outperform |
| Oct-19-20 | Initiated | Credit Suisse | Outperform |
| Oct-19-20 | Initiated | Deutsche Bank | Hold |
| Oct-19-20 | Initiated | Goldman | Neutral |
| Oct-19-20 | Initiated | JP Morgan | Neutral |
| Oct-19-20 | Initiated | Morgan Stanley | Overweight |
| Oct-19-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-19-20 | Initiated | SVB Leerink | Outperform |
| Oct-19-20 | Initiated | UBS | Buy |
View All
Goodrx Holdings Inc Stock (GDRX) Latest News
Custom watchlist performance reports with GoodRx Holdings Inc.Global Markets & Expert Approved Trade Ideas - newser.com
Does GoodRx Holdings Inc. fit your quant trading modelWeekly Gains Report & Accurate Intraday Trade Tips - newser.com
How strong is GoodRx Holdings Inc. stock revenue growthJuly 2025 Market Mood & Proven Capital Preservation Methods - newser.com
Can GoodRx Holdings Inc. stock double in next 5 yearsMarket Performance Report & Stock Portfolio Risk Control - newser.com
How currency fluctuations impact GoodRx Holdings Inc. stockChart Signals & Risk Managed Investment Signals - newser.com
Ranking GoodRx Holdings Inc. among high performing stocks via tools2025 Valuation Update & Safe Capital Growth Tips - newser.com
Using Ichimoku Cloud for GoodRx Holdings Inc. technicalsMarket Movement Recap & Fast Entry Momentum Alerts - newser.com
Smart tools for monitoring GoodRx Holdings Inc.’s price actionMarket Volume Report & Long Hold Capital Preservation Tips - newser.com
Is GoodRx Holdings Inc. meeting your algorithmic filter criteriaStop Loss & Daily Entry Point Trade Alerts - newser.com
Measuring GoodRx Holdings Inc.’s beta against major indicesWeekly Investment Summary & Fast Moving Trade Plans - newser.com
How GoodRx Holdings Inc. stock performs after earnings2025 Analyst Calls & Momentum Based Trading Signals - newser.com
Central Ohio Rx delivery tech company acquired for half what it raised in venture capital - The Business Journals
Risk adjusted return profile for GoodRx Holdings Inc. analyzedJuly 2025 Earnings & Trade Opportunity Analysis Reports - newser.com
GoodRx Holdings Inc Stock Analysis and ForecastIndustrial Stocks Review & Rapid Profit Growth - earlytimes.in
GoodRx Holdings' (NASDAQ:GDRX) Earnings May Just Be The Starting Point - Yahoo Finance
JP Morgan Lowers GoodRx (GDRX) Price Target; Rating Remains Over - GuruFocus
Quantitative breakdown of GoodRx Holdings Inc. recent moveJuly 2025 Fed Impact & Long-Term Safe Investment Ideas - newser.com
Detecting price anomalies in GoodRx Holdings Inc. with AI2025 Key Lessons & Safe Capital Allocation Plans - newser.com
Reversal indicators forming on GoodRx Holdings Inc. stock2025 Sector Review & Community Shared Stock Ideas - newser.com
Investors Don't See Light At End Of GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Tunnel And Push Stock Down 27% - 富途牛牛
GDRX: TD Cowen Lowers GoodRx Holdings Price Target to $6 | GDRX Stock News - GuruFocus
GoodRx stock price target lowered to $6 by TD Cowen on PTR growth challenges - Investing.com Nigeria
Is GoodRx Holdings Inc. still worth holding after the dipJuly 2025 Opening Moves & Advanced Technical Signal Analysis - newser.com
GoodRx Holdings Inc. (GDRX) PT Lowered to $6 at TD Cowen - StreetInsider
How analysts rate GoodRx Holdings Inc. stock todayTrade Risk Assessment & Accurate Technical Buy Alerts - newser.com
Local Firms Advance Hair Loss Treatment - Los Angeles Business Journal
Goodrx Holdings Inc Stock (GDRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):